Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ORMP

Oramed Pharmaceuticals (ORMP)

Oramed Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ORMP
DateTimeSourceHeadlineSymbolCompany
27/09/202306:34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORMPOramed Pharmaceuticals Inc
23/09/202301:38PR Newswire (US)Sorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding CompanyNASDAQ:ORMPOramed Pharmaceuticals Inc
22/09/202308:11PR Newswire (US)Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding CompanyNASDAQ:ORMPOramed Pharmaceuticals Inc
22/09/202306:05GlobeNewswire Inc.Scilex Holding Company Announces the Consummation of the Previously Announced Purchase of all of the Scilex Common Shares, Preferred Shares and Warrants Owned by Sorrento Therapeutics, Inc.NASDAQ:ORMPOramed Pharmaceuticals Inc
13/09/202323:00GlobeNewswire Inc.Scilex Holding Company Enters into Non-Binding Term Sheets for the Purchase of all of the Scilex Common Shares, Preferred Shares, and Warrants Currently Owned by Sorrento Therapeutics, Inc. and is Declared the New Successful BidderNASDAQ:ORMPOramed Pharmaceuticals Inc
13/09/202322:47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORMPOramed Pharmaceuticals Inc
11/08/202307:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORMPOramed Pharmaceuticals Inc
09/08/202322:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORMPOramed Pharmaceuticals Inc
07/08/202323:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORMPOramed Pharmaceuticals Inc
02/08/202321:45PR Newswire (US)Oramed Signs Term Sheet with HTIT to Create a Joint Venture to Advance Oral Drug Delivery Technology GloballyNASDAQ:ORMPOramed Pharmaceuticals Inc
14/07/202307:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORMPOramed Pharmaceuticals Inc
20/06/202321:55PR Newswire (US)Oramed to Present at the 83rd American Diabetes Association ConferenceNASDAQ:ORMPOramed Pharmaceuticals Inc
18/05/202321:55PR Newswire (US)Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity SummitNASDAQ:ORMPOramed Pharmaceuticals Inc
15/05/202323:05PR Newswire (US)Oramed Announces that its Chinese Partner, HTIT, has Successfully Completed a Phase 3 Oral Insulin Clinical Trial and Submitted a Marketing Authorization Application in ChinaNASDAQ:ORMPOramed Pharmaceuticals Inc
12/05/202307:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ORMPOramed Pharmaceuticals Inc
02/05/202307:08Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ORMPOramed Pharmaceuticals Inc
02/05/202306:53Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
02/05/202306:45PR Newswire (US)Oramed Appoints Ben Shapiro to its Board of DirectorsNASDAQ:ORMPOramed Pharmaceuticals Inc
20/04/202320:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
20/04/202320:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
20/04/202320:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
20/04/202320:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
20/04/202320:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
20/04/202320:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
20/04/202320:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
20/04/202320:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
17/03/202308:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
16/03/202308:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
16/03/202308:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
16/03/202308:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ORMP